X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (33202) 33202
Publication (3419) 3419
Book Review (392) 392
Patent (189) 189
Book Chapter (122) 122
Conference Proceeding (72) 72
Book / eBook (45) 45
Dissertation (20) 20
Magazine Article (9) 9
Newsletter (7) 7
Data Set (5) 5
Presentation (4) 4
Reference (3) 3
Paper (2) 2
Government Document (1) 1
Streaming Video (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27384) 27384
index medicus (18595) 18595
female (14640) 14640
oncology (14257) 14257
male (11578) 11578
antineoplastic combined chemotherapy protocols - therapeutic use (10931) 10931
animals (10052) 10052
combined modality therapy (9492) 9492
middle aged (8361) 8361
cancer (8342) 8342
chemotherapy (7072) 7072
adult (7060) 7060
aged (7027) 7027
mice (6186) 6186
treatment outcome (5978) 5978
cell line, tumor (4991) 4991
care and treatment (4432) 4432
antineoplastic combined chemotherapy protocols - pharmacology (4271) 4271
apoptosis (4010) 4010
pharmacology & pharmacy (3392) 3392
research (3311) 3311
therapy (3241) 3241
antineoplastic combined chemotherapy protocols - adverse effects (3218) 3218
drug synergism (3140) 3140
analysis (3132) 3132
medicine & public health (3037) 3037
apoptosis - drug effects (3024) 3024
antineoplastic agents - therapeutic use (2959) 2959
tumors (2923) 2923
expression (2820) 2820
health aspects (2753) 2753
hematology (2752) 2752
antineoplastic combined chemotherapy protocols - administration & dosage (2683) 2683
prognosis (2625) 2625
dose-response relationship, drug (2561) 2561
inhibition (2386) 2386
xenograft model antitumor assays (2372) 2372
aged, 80 and over (2349) 2349
drug therapy (2330) 2330
mice, nude (2289) 2289
article (2253) 2253
cell proliferation - drug effects (2187) 2187
metastasis (2104) 2104
hematology, oncology and palliative medicine (2055) 2055
breast cancer (1978) 1978
survival (1948) 1948
breast neoplasms - drug therapy (1928) 1928
lung neoplasms - drug therapy (1865) 1865
radiotherapy (1854) 1854
clinical trials (1853) 1853
antineoplastic agents - pharmacology (1836) 1836
neoplasm staging (1814) 1814
disease-free survival (1778) 1778
cisplatin (1752) 1752
cancer therapies (1750) 1750
antineoplastic agents (1739) 1739
carcinoma (1714) 1714
immunotherapy (1701) 1701
surgery (1679) 1679
neoplasms - drug therapy (1669) 1669
time factors (1666) 1666
cells (1657) 1657
combination (1641) 1641
tumor cells, cultured (1616) 1616
antimitotic agents (1615) 1615
in-vitro (1590) 1590
growth (1585) 1585
cisplatin - administration & dosage (1569) 1569
drug administration schedule (1558) 1558
proteins (1518) 1518
survival rate (1507) 1507
cancer research (1503) 1503
antineoplastic agents - administration & dosage (1481) 1481
mice, inbred balb c (1480) 1480
fluorouracil - administration & dosage (1475) 1475
adolescent (1466) 1466
immunology (1465) 1465
survival analysis (1451) 1451
clinical trials as topic (1440) 1440
drug resistance, neoplasm (1439) 1439
cell biology (1436) 1436
medicine, research & experimental (1424) 1424
deoxycytidine - analogs & derivatives (1422) 1422
angiogenesis (1401) 1401
mutation (1387) 1387
trial (1381) 1381
signal transduction - drug effects (1377) 1377
medicine (1352) 1352
cell survival - drug effects (1320) 1320
follow-up studies (1320) 1320
rats (1315) 1315
biochemistry & molecular biology (1293) 1293
activation (1286) 1286
toxicity (1278) 1278
breast-cancer (1267) 1267
in-vivo (1265) 1265
gene expression (1256) 1256
breast neoplasms - pathology (1246) 1246
bevacizumab (1244) 1244
resistance (1233) 1233
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (24) 24
Robarts - Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Online Resources - Online (3) 3
UofT at Mississauga - Stacks (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Engineering & Comp. Sci. - Stacks (1) 1
OISE - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (32955) 32955
Japanese (200) 200
German (155) 155
French (115) 115
Chinese (91) 91
Russian (84) 84
Spanish (12) 12
Korean (11) 11
Polish (7) 7
Czech (6) 6
Italian (6) 6
Portuguese (6) 6
Dutch (5) 5
Hungarian (5) 5
Danish (4) 4
Norwegian (2) 2
Swedish (2) 2
Ukrainian (2) 2
Bosnian (1) 1
Bulgarian (1) 1
Croatian (1) 1
Lithuanian (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular Cancer Therapeutics, ISSN 1535-7163, 05/2018, Volume 17, Issue 5, pp. 908 - 920
The cyclin dependent kinase (CDK)-retinoblastoma (RB)-E2F pathway plays a critical role in the control of cell cycle in estrogen receptor-positive (ER+) breast... 
CELLS | PALBOCICLIB | THERAPY | CDK6 | ONCOLOGY | PHOSPHORYLATION | PROGRESSION-FREE SURVIVAL | TRANSCRIPTION | GENE-EXPRESSION | RESISTANCE | SENESCENCE | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Piperazines - administration & dosage | Receptors, Estrogen - metabolism | Pyridines - administration & dosage | TOR Serine-Threonine Kinases - metabolism | Humans | Morpholines - administration & dosage | Cyclin-Dependent Kinase 6 - metabolism | Cyclin-Dependent Kinase 4 - metabolism | Mice, SCID | Breast Neoplasms - drug therapy | E2F Transcription Factors - metabolism | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Breast Neoplasms - metabolism | TOR Serine-Threonine Kinases - antagonists & inhibitors | Xenograft Model Antitumor Assays | Animals | E2F Transcription Factors - antagonists & inhibitors | MCF-7 Cells | Breast Neoplasms - pathology | Cell Line, Tumor | Female | Cell Proliferation - drug effects | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | TOR protein | Biotechnology | Phosphorylation | Transcription factors | D1 protein | Xenotransplantation | Estrogens | Clinical trials | Estrogen receptors | Cyclin D1 | Kinases | Cyclin-dependent kinase 4 | Cyclin-dependent kinase | E2F protein | Cell cycle | Xenografts | Inhibition | Medical research | Retinoblastoma protein | Breast cancer | Tumor cell lines | 1-Phosphatidylinositol 3-kinase | Inhibitors | Cell lines | Breast | Retinoblastoma | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2014, Volume 371, Issue 20, pp. 1877 - 1888
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2015, Volume 21, Issue 24, pp. 5412 - 5414
In the January 15, 2012, issue of Clinical Cancer Research, Kirkwood and colleagues published a study comparing the MEK inhibitor selumetinib with temozolomide... 
TRIAL | MEK | ONCOLOGY | PHASE-II | SELUMETINIB | OPEN-LABEL | BRAF | AZD6244 ARRY-142886 | BLOCKADE | DOCETAXEL | PROGRESSION | Animals | Extracellular Signal-Regulated MAP Kinases - drug effects | Benzimidazoles - administration & dosage | Humans | Melanoma - drug therapy | Cell Proliferation - drug effects | Antineoplastic Combined Chemotherapy Protocols - pharmacology
Journal Article
Circulation, ISSN 0009-7322, 12/2007, Volume 116, Issue 25, pp. 2923 - 2932
Journal Article
Autophagy, ISSN 1554-8627, 08/2014, Volume 10, Issue 8, pp. 1391 - 1402
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2004, Volume 44, Issue 9, pp. 1792 - 1800
Journal Article
Journal Article
Autophagy, ISSN 1554-8627, 08/2014, Volume 10, Issue 8, pp. 1380 - 1390
Journal Article
Circulation, ISSN 0009-7322, 08/2011, Volume 124, Issue 5, pp. 544 - 554
Journal Article
Autophagy, ISSN 1554-8627, 08/2014, Volume 10, Issue 8, pp. 1403 - 1414
Journal Article
Advanced Materials, ISSN 0935-9648, 08/2014, Volume 26, Issue 32, pp. 5646 - 5652
Journal Article